Efficacy of QIANLIEHUICHUN Capsule on the Treatment of Type III Chronic Prostatitis
Wujiang Liu
Abstract
Wujiang Liu
Abstract
Objective:To investigate the clinical efficacy of the QIANLIEHUICHUN capsule on the treatment of type Ⅲ chronic prostatitis.Methods:54 cases of chronic nonbacterial prostatitis/chronic pelvic pain syndrome(CPPS) were divided into type ⅢA 28 cases,ⅢB 26 cases.All cases were given to the QIANLIEHUICHUN capsule treatment(1.8 g/time,3 times a day,lasted for 3 months).The changes of the U.S.National Institutes of Health chronic prostatitis symptom index(NIH-CPSI) score were recorded before and after treatment.Also,examination of EPS also used as an index to compare the response of patients with type ⅢA and ⅢB chronic prostatitis.Results:The overall effective rate was 68.0%(17/25) in patients with type ⅢA,38.5%(10/26) in patients with type ⅢB.The statistical analysis showed that changes of the NIH-CPSI was much different between the two types of patients with chronic prostatitis(P0.05).Conclusion:QIANLIEHUICHUN capsule has different therapeutical effect on different type of chronic prostatitis.It is important to identify the type of chronic prostatitis for improving its therapeutical effect.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the clinical efficacy of the QIANLIEHUICHUN capsule on the treatment of type Ⅲ chronic prostatitis.Methods:54 cases of chronic nonbacterial prostatitis/chronic pelvic pain syndrome(CPPS) were divided into type ⅢA 28 cases,ⅢB 26 cases.All cases were given to the QIANLIEHUICHUN capsule treatment(1.8 g/time,3 times a day,lasted for 3 months).The changes of the U.S.National Institutes of Health chronic prostatitis symptom index(NIH-CPSI) score were recorded before and after treatment.Also,examination of EPS also used as an index to compare the response of patients with type ⅢA and ⅢB chronic prostatitis.Results:The overall effective rate was 68.0%(17/25) in patients with type ⅢA,38.5%(10/26) in patients with type ⅢB.The statistical analysis showed that changes of the NIH-CPSI was much different between the two types of patients with chronic prostatitis(P0.05).Conclusion:QIANLIEHUICHUN capsule has different therapeutical effect on different type of chronic prostatitis.It is important to identify the type of chronic prostatitis for improving its therapeutical effect.
Key concepts: Prostatitis, Medicine, Capsule, Internal medicine, Gastroenterology, Urology, Prostate, Biology